Kellyann Niotis

ORCID: 0000-0001-5819-2082

Also affiliated with Icahn School of Medicine at Mount Sinai

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Who to Enroll in Parkinson Disease Prevention Trials?”.

Who to Enroll in Parkinson Disease Prevention Trials?

Neurology(2022)10.1212/wnl.0000000000200812

N/A

0DataRank · unranked

11 citations

Andrew B. West, Rachel Saunders‐Pullman, Kellyann Niotis

Comparing the effects of four common drug classes on the progression of mild cognitive impairment to dementia using electronic health records

Scientific Reports(2023)10.1038/s41598-023-35258-6

N/A

0DataRank · unranked

11 citations

Fei Wang, Chengxi Zang, Hao Zhang, Kellyann Niotis, Ava L. Liberman +14 more

Smoking predicts brain atrophy in 10,134 healthy individuals and is potentially influenced by body mass index

npj Dementia(2025)10.1038/s44400-025-00024-0

N/A

0DataRank · unranked

2 citations

Saurabh K. Garg†, Sam Hashemi, Nasrin Akbari, Ahmed Gouda, Yosef Gavriel Chodakiewitz +6 more